PRPH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PRPH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-06-07), ProPhase Labs's current share price is $4.64. ProPhase Labs's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $2.29. ProPhase Labs's Cyclically Adjusted PB Ratio for today is 2.03.
The historical rank and industry rank for ProPhase Labs's Cyclically Adjusted PB Ratio or its related term are showing as below:
During the past years, ProPhase Labs's highest Cyclically Adjusted PB Ratio was 13.79. The lowest was 0.90. And the median was 2.06.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
ProPhase Labs's adjusted book value per share data for the three months ended in Mar. 2024 was $2.486. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.29 for the trailing ten years ended in Mar. 2024.
The historical data trend for ProPhase Labs's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ProPhase Labs Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted PB Ratio | Get a 7-Day Free Trial | 3.78 | 3.45 | 2.01 | 2.04 | 2.82 |
For the Diagnostics & Research subindustry, ProPhase Labs's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, ProPhase Labs's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where ProPhase Labs's Cyclically Adjusted PB Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
ProPhase Labs's Cyclically Adjusted PB Ratio for today is calculated as
Cyclically Adjusted PB Ratio | = | Share Price | / | Cyclically Adjusted Book per Share |
= | 4.64 | / | 2.29 | |
= | 2.03 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ProPhase Labs's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, ProPhase Labs's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:
Adj_Book | = | Book Value per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 2.486 | / | 131.7762 | * | 131.7762 | |
= | 2.486 |
Current CPI (Mar. 2024) = 131.7762.
ProPhase Labs Quarterly Data
Book Value per Share | CPI | Adj_Book | |
201406 | 0.705 | 100.560 | 0.924 |
201409 | 0.681 | 100.428 | 0.894 |
201412 | 0.674 | 99.070 | 0.897 |
201503 | 0.590 | 99.621 | 0.780 |
201506 | 0.512 | 100.684 | 0.670 |
201509 | 0.588 | 100.392 | 0.772 |
201512 | 0.517 | 99.792 | 0.683 |
201603 | 0.439 | 100.470 | 0.576 |
201606 | 0.373 | 101.688 | 0.483 |
201609 | 0.383 | 101.861 | 0.495 |
201612 | 0.349 | 101.863 | 0.451 |
201703 | 2.958 | 102.862 | 3.789 |
201706 | 2.885 | 103.349 | 3.679 |
201709 | 2.949 | 104.136 | 3.732 |
201712 | 2.861 | 104.011 | 3.625 |
201803 | 2.976 | 105.290 | 3.725 |
201806 | 1.780 | 106.317 | 2.206 |
201809 | 1.707 | 106.507 | 2.112 |
201812 | 1.429 | 105.998 | 1.777 |
201903 | 1.359 | 107.251 | 1.670 |
201906 | 1.267 | 108.070 | 1.545 |
201909 | 1.245 | 108.329 | 1.514 |
201912 | 0.970 | 108.420 | 1.179 |
202003 | 0.918 | 108.902 | 1.111 |
202006 | 0.940 | 108.767 | 1.139 |
202009 | 0.927 | 109.815 | 1.112 |
202012 | 0.910 | 109.897 | 1.091 |
202103 | 3.475 | 111.754 | 4.098 |
202106 | 3.150 | 114.631 | 3.621 |
202109 | 3.083 | 115.734 | 3.510 |
202112 | 3.786 | 117.630 | 4.241 |
202203 | 4.291 | 121.301 | 4.662 |
202206 | 4.335 | 125.017 | 4.569 |
202209 | 4.238 | 125.227 | 4.460 |
202212 | 3.925 | 125.222 | 4.130 |
202303 | 3.557 | 127.348 | 3.681 |
202306 | 3.518 | 128.729 | 3.601 |
202309 | 3.127 | 129.860 | 3.173 |
202312 | 2.737 | 129.419 | 2.787 |
202403 | 2.486 | 131.776 | 2.486 |
Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Thank you for viewing the detailed overview of ProPhase Labs's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Morse Robert A. Jr. | officer: Controller | 711 STEWART AVENUE, SUITE 200, GARDEN CITY NY 11530 |
Billy Joe White | officer: Chief Financial Officer | 191 OTTO ST., PORT TOWNSEND WA 98368 |
Jason Michael Barr | director | 902 BROADWAY, 15TH FLOOR, NEW YORK NY 10010 |
Louis Md Gleckel | 10 percent owner | C/O PROHEALTH CARE ASSOCIATES LLP, 2800 METRUS AVE, LAKE SUCCESS NY 11042 |
Ted William Karkus | 10 percent owner | 188 HEWLETT NECK ROAD, WOODMERE NY 11598 |
Warren Hirsch | director | 621 N. SHADY RETREAT ROAD, DOYLESTOWN PA 18901 |
Monica L. Brady | officer: Chief Accounting Officer | 621 N. SHADY RETREAT ROAD, DOYLESTOWN PA 18901 |
Cuddihy Robert V Jr | officer: Chief Operating Officer | PARKER DURYEE ET AL, 529 FIFTH AVE 8TH FL, NEW YORK NY 10017 |
Braden Michael Leonard | 10 percent owner | 156 S. FIRST STREET, ZIONSVILLE IN 46077 |
Mark S Leventhal | 10 percent owner | THE BEACON COMPANIES, 50 FEDERAL STREET, BOSTON MA 02468 |
Mark Shawn Frank | director | 104 WHISPER WOOD COURT, WRIGHTSTOWN PA 18940 |
James T Mccubbin | director | |
Mark A. Burnett | 10 percent owner | 40 HEMLOCK DRIVE, ROSLYN NY 11576 |
Guy J Quigley | director, 10 percent owner, officer: Chairman, President, CEO | C/O THE QUIGLEY CORP KELLS BUILDINGS, 621 SHADY RETREAT RD P O BOX 1349, DOYLESTOWN PA 18901 |
John Deshazo | 10 percent owner | 17 WOLCOTT COURT, BOSTON MA 02136 |
From GuruFocus
By sperokesalga sperokesalga • 06-01-2023
By Marketwired • 10-12-2023
By Stock market mentor Stock market mentor • 02-06-2023
By sperokesalga sperokesalga • 02-15-2023
By Marketwired • 08-02-2023
By Marketwired • 08-10-2023
By sperokesalga sperokesalga • 05-03-2023
By sperokesalga sperokesalga • 04-28-2023
By Stock market mentor Stock market mentor • 01-05-2023